Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat - Archives of Toxicology
- ️Martin, Elizabeth A.
- ️Wed Aug 01 2001
Abstract.
Tamoxifen is a potent rat liver carcinogen, currently being used as a long-term chemopreventative for breast cancer in healthy women. The mechanism by which tamoxifen causes liver cancer in rats is known to be associated with the accumulation of tamoxifen DNA adducts in this organ. We have examined the dose-response relationship of tamoxifen-induced DNA adducts in the liver and the subsequent increase in the development of liver cancer, with and without phenobarbital promotion. Female Wistar (Han) rats were fed 420 ppm tamoxifen in the diet for 0, 1, 4, 8 or 12 weeks after which time rats were either examined immediately for hepatic tamoxifen-induced DNA damage using the 32P-postlabelling assay, or left for lifetime for tumour assessment. A proportion of rats left for lifetime study were given phenobarbital in their drinking water. There was a clear dose-response relationship with respect to duration of tamoxifen exposure for both accumulation of DNA adducts and lifetime risk of liver cancer. In the absence of phenobarbital promotion there was a threshold value for tamoxifen-induced DNA adducts (180 adducts/108 nucleotides) and the subsequent induction of liver cancer. This study demonstrates the relationship between the accumulation of hepatic tamoxifen-induced DNA adducts and the development of liver cancer and establishes the threshold for hepatocarcinogenesis in terms of DNA adduct formation. These data could provide useful information in interpreting the relevance of low levels of DNA adducts in humans.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
SEAC Toxicology Unit, Unilever Research, Colworth House, Sharnbrook, Bedfordshire MK44 1LQ, UK, , , , ,
Philip Carthew
PN Lee Statistics and Computing Ltd, Hamilton House, 17 Cedar Rd, Sutton, Surrey SM2 5DA, UK, , , , ,
Peter N. Lee
MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK, , , , ,
Richard E. Edwards, Robert T. Heydon, Barbara M. Nolan & Elizabeth A. Martin
Authors
- Philip Carthew
You can also search for this author inPubMed Google Scholar
- Peter N. Lee
You can also search for this author inPubMed Google Scholar
- Richard E. Edwards
You can also search for this author inPubMed Google Scholar
- Robert T. Heydon
You can also search for this author inPubMed Google Scholar
- Barbara M. Nolan
You can also search for this author inPubMed Google Scholar
- Elizabeth A. Martin
You can also search for this author inPubMed Google Scholar
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Carthew, P., Lee, P.N., Edwards, R.E. et al. Cumulative exposure to tamoxifen: DNA adducts and liver cancer in the rat. Arch Toxicol 75, 375–380 (2001). https://doi.org/10.1007/s002040100244
Received: 15 January 2001
Accepted: 25 April 2001
Issue Date: August 2001
DOI: https://doi.org/10.1007/s002040100244